Immix Biopharma, Inc. - Common Stock (NQ:IMMX)
8.750
-0.050
(-0.57%)
Streaming Delayed Price
Updated: 12:15 PM EDT, Jul 24, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,317,788 |
| Open | 8.880 |
| Bid (Size) | 8.750 (800) |
| Ask (Size) | 8.770 (200) |
| Prev. Close | 8.800 |
| Today's Range | 8.510 - 8.990 |
| 52wk Range | 1.940 - 12.14 |
| Shares Outstanding | 33,577,873 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
November 12, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 07, 2025
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 08, 2025
Frequently Asked Questions
Is Immix Biopharma, Inc. - Common Stock publicly traded?
Yes, Immix Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Immix Biopharma, Inc. - Common Stock trade on?
Immix Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immix Biopharma, Inc. - Common Stock?
The ticker symbol for Immix Biopharma, Inc. - Common Stock is IMMX on the Nasdaq Stock Market
What is the current price of Immix Biopharma, Inc. - Common Stock?
The current price of Immix Biopharma, Inc. - Common Stock is 8.750
When was Immix Biopharma, Inc. - Common Stock last traded?
The last trade of Immix Biopharma, Inc. - Common Stock was at 07/24/26 12:15 PM ET
What is the market capitalization of Immix Biopharma, Inc. - Common Stock?
The market capitalization of Immix Biopharma, Inc. - Common Stock is 293.81M
How many shares of Immix Biopharma, Inc. - Common Stock are outstanding?
Immix Biopharma, Inc. - Common Stock has 294M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.